Tandem autologous stem cell transplantation for multiple myeloma: is it applicable and effective outside clinical trials?
Dimopoulos
Meletios A
MA
Department of Clinical Therapeutics University of Athens School of Medicine, Athens, Greece. mdimop@med.uoa.gr
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019090:Case Management; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D018450:Disease Progression; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy / Q000601:surgery*; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D014182:Transplantation, Autologous; D016896:Treatment Outcome